To Treat or Not To Treat, That Is the Question: Proceedings of the Quebec Symposium for the Treatment of Osteoporosis in Long-Term Care Institutions, Saint-Hyacinthe, Quebec, November 5, 2004

Journal of the American Medical Directors Association

Volumn 8, Issue 3 SUPPL. 2, 2007, Pages

  Duque, Gustavo ^a,c   Mallet, Louise ^a,b   Roberts, Ayanna ^a   Gingrass, Serge ^d   Kremer, Richard ^d   Sainte Marie, Louis Georges ^b   Kiel, Douglas P ^e  

^a MCGILL UNIVERSITY   (Canada)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

^c Centre d'hébergement de Longue Durée   (Canada)

^d MCGILL UNIVERSITY   (Canada)

^e HARVARD MEDICAL SCHOOL   (United States)

Author keywords

biphosphonates; calcium; fractures; Long term care; osteoporosis; vitamin D

Indexed keywords

ALENDRONIC ACID; ANABOLIC AGENT; ANALGESIC AGENT; ANTILIPEMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BISPHOSPHONIC ACID DERIVATIVE; CALCITONIN; CALCIUM; COLECALCIFEROL; ESTROGEN; IBANDRONIC ACID; PAMIDRONIC ACID; PARATHYROID HORMONE; PARATHYROID HORMONE[1-34]; PLACEBO; RALOXIFENE; RISEDRONIC ACID; SELECTIVE ESTROGEN RECEPTOR MODULATOR; VITAMIN D;

AGED; ARTICLE; BONE DENSITY; CANADA; CASE MANAGEMENT; CLINICAL PRACTICE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; COST OF ILLNESS; DECISION MAKING; DIAGNOSTIC ERROR; DIAGNOSTIC TEST; DIAGNOSTIC VALUE; DRUG TOLERABILITY; EVIDENCE BASED MEDICINE; FRAGILITY FRACTURE; FRAIL ELDERLY; HEART INFARCTION; HIGH RISK PATIENT; HUMAN; KINESIOTHERAPY; LABORATORY TEST; LIFE EXPECTANCY; LONG TERM CARE; MALNUTRITION; MEDICAL SPECIALIST; NURSING HOME PATIENT; OSTEOPOROSIS; PATIENT COMPLIANCE; PATIENT MOBILITY; PHARMACIST; PHYSICIAN; POLYPHARMACY; POSTMENOPAUSE OSTEOPOROSIS; PRACTICE GUIDELINE; PROGNOSIS; RISK FACTOR; SCREENING; SENILE OSTEOPOROSIS; SUN EXPOSURE; TREATMENT INDICATION; TREATMENT PLANNING; UNSPECIFIED SIDE EFFECT; VERTEBRA FRACTURE;

EID: 33847666914     PISSN: 15258610     EISSN: 15389375     Source Type: Journal    
DOI: 10.1016/j.jamda.2006.12.010     Document Type: Article

References (39)

1. Medina-Walpole A., and Katz P.R. Nursing home care. In: Hazzard W.R., Blass J.P., Halter J.B., and Ouslander J.G. (Eds). Principles of Geriatric Medicine and Gerontology. 5th ed. (2003), McGraw Hill, New York
2. Ooms M.E., Vlasman P., Lips P., et al. The incidence of hip fractures in independent and institutionalized elderly people. Osteoporos Int 4 (1994) 6-10
3. Girman C.J., Chandler J.M., Zimmerman S.I., et al. Prediction of fracture in nursing home residents. J Am Geriatr Soc 50 (2002) 1341-1347
4. Wallace R.B. Bone health in nursing home residents. Jama 284 (2000) 1018-1019
5. Chandler J.M., Zimmerman S.I., Girman C.J., et al. Low bone mineral density and risk of fracture in white female nursing home residents. Jama 284 (2000) 972-977
6. Greenspan S.L., Myers E.R., Kiel D.P., et al. Fall direction, bone mineral density, and function: Risk factors for hip fracture in frail nursing home elderly. Am J Med 104 (1998) 539-545
7. Gloth III F.M. Osteoporosis in long term care. Part 1 of 2: Recognizing bone and beyond. Director 12 (2004) 175-176 179-180
8. Broe K.E., Hannan M.T., Kiely D.K., et al. Predicting fractures using bone mineral density: a prospective study of long-term care residents. Osteoporos Int 11 (2000) 765-771
9. Zimmerman S.I., Girman C.J., Buie V.C., et al. The prevalence of osteoporosis in nursing home residents. Osteoporos Int 9 (1999) 151-157
10. Zimmerman S., Chandler J.M., Hawkes W., et al. Effect of fracture on the health care use of nursing home residents. Arch Intern Med 162 (2002) 1502-1508
11. Ray N.F., Chan J.K., Thamer M., et al. Medical expenditures for the treatment of osteoporotic fractures in the United States in 1995: Report from the National Osteoporosis Foundation. J Bone Miner Res 12 (1997) 24-35
12. Hajjar R.R., and Kamel H.K. Osteoporosis for the home care physician. Part 1: Etiology and current diagnostic strategies. J Am Med Dir Assoc 5 (2004) 192-196
13. Schousboe J.T., Ensrud K.E., Nyman J.A., et al. Universal bone densitometry screening combined with alendronate therapy for those diagnosed with osteoporosis is highly cost-effective for elderly women. J Am Geriatr Soc 53 (2005) 1697-1704
14. Gupta G., and Aronow W.S. Underuse of procedures for diagnosing osteoporosis and of therapies for osteoporosis in older nursing home residents. J Am Med Dir Assoc 4 (2003) 200-202
15. Elliott M.E., Binkley N.C., Carnes M., et al. Fracture risks for women in long-term care: High prevalence of calcaneal osteoporosis and hypovitaminosis D. Pharmacotherapy 23 (2003) 702-710
16. Brown J.P., Josse R.G., and Scientific Advisory Council of the Osteoporosis Society of Canada. 2002 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada. Cmaj 167 (2002) 1-34
17. Saliba D., Solomon D., Rubenstein L., et al. Quality indicators for the management of medical conditions in nursing home residents. J Am Med Dir Assoc 5 (2004) 297-309
18. Kamel H.K. Underutilization of calcium and vitamin D supplements in an academic long-term care facility. J Am Med Dir Assoc 5 (2004) 98-100
19. Jachna C.M., Shireman T.I., Whittle J., et al. Differing patterns of antiresorptive pharmacotherapy in nursing facility residents and community dwellers. J Am Geriatr Soc 53 (2005) 1275-1281
20. Bergman H., and Montambault J. Services d'hébergement. In: Arcand M., and Hébert R. (Eds). Précis pratique de gériatrie. 2nd ed. (1997), Maloine, Fédération des médecins omnipraticiens du Québec, St-Hyacinthe, Quebec
21. Bischoff-Ferrari H.A., Willett W.C., Wong J.B., et al. Fracture prevention with vitamin D supplementation: A meta-analysis of randomized controlled trials. Jama 293 (2005) 2257-2264
22. Roux C., Seeman E., Eastell R., et al. Efficacy of risedronate on clinical vertebral fractures within six months. Curr Med Res Opin 20 (2004) 433-439
23. Vu M.Q., Weintraub N., and Rubenstein L.Z. Falls in the nursing home: Are they preventable?. J Am Med Dir Assoc 5 (2004) 401-406
24. Caro J.J., Ishak K.J., Huybrechts K.F., et al. The impact of compliance with osteoporosis therapy on fracture rates in actual practice. Osteoporos Int 15 (2004) 1003-1008
25. Lips P., and Ooms M.E. Non-pharmacological interventions. Baillieres Best Pract Res Clin Endocrinol Metab 14 (2000) 265-277
26. Singh S., Sun H., and Anis A.H. Cost-effectiveness of hip protectors in the prevention of osteoporosis related hip fractures in elderly nursing home residents. J Rheumatol 31 (2004) 1607-1613
27. Bischoff-Ferrari H.A., Orav E.J., and Dawson-Hughes B. Effect of cholecalciferol plus calcium on falling in ambulatory older men and women: A 3-year randomized controlled trial. Arch Intern Med 166 (2006) 424-430
28. Bischoff-Ferrari H.A., Willett W.C., Wong J.B., et al. Fracture prevention with vitamin D supplementation: A meta-analysis of randomized controlled trials. JAMA 293 (2005) 2257-2264
29. Porthouse J., Cockayne S., King C., et al. Randomised controlled trial of calcium and supplementation with cholecalciferol (vitamin D3) for prevention of fractures in primary care. BMJ 330 (2005) 1003
30. Grant A.M., Avenell A., Campbell M.K., et al., RECORD Trial Group. Oral vitamin D3 and calcium for secondary prevention of low-trauma fractures in elderly people (Randomised Evaluation of Calcium Or vitamin D, RECORD): A randomised placebo-controlled trial. Lancet 365 (2005) 1621-1628
31. Jackson R.D., LaCroix A.Z., Gass M., et al., Women's Health Initiative Investigators. Calcium plus vitamin D supplementation and the risk of fractures. N Engl J Med 354 (2006) 669-683
32. Vecino C., Gratton M., Kremer R., et al. The seasonal variance in serum levels of vitamin D determines a compensatory response by parathyroid hormone: Study in an ambulatory elderly population in Quebec. Gerontology 52 1 (2006) 33-39
33. Greenspan S.L., Schneider D.L., McClung M.R., et al. Alendronate improves bone mineral density in elderly women with osteoporosis residing in long-term care facilities. A randomized, double-blind, placebo-controlled trial. Ann Intern Med 136 (2002) 742-746
34. Black D.M., Cummings S.R., Karpf D.B., et al., Fracture Intervention Trial Research Group. Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Lancet 348 (1996) 1535-1541
35. McClung M.R., Geusens P., Miller P.D., et al., Hip Intervention Program Study Group. Effect of risedronate on the risk of hip fracture in elderly women. N Engl J Med 344 (2001) 333-340
36. Lyritis G.P., Ioannidis G.V., Karachalios T., et al. Analgesic effect of salmon calcitonin suppositories in patients with acute pain due to recent osteoporotic vertebral crush fractures: A prospective double-blind, randomized, placebo-controlled clinical study. Clin J Pain 15 (1999) 284-289
37. Writing Group for the Women's Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy post-menopausal women. Jama 288 (2002) 321-333
38. Hansdottir H., Franzson L., Prestwood K., et al. The effect of raloxifene on markers of bone turnover in older women living in long-term care facilities. J Am Geriatr Soc 52 (2004) 779-783
39. Hodsman A.B., Bauer D.C., Dempster D.W., et al. Parathyroid hormone and teriparatide for the treatment of osteoporosis: A review of the evidence and suggested guidelines for its use. Endocr Rev 26 (2005) 688-703